Trademark: 79171327
Word
BAXALTA
Status
Registered
Status Code
707
Status Date
Friday, February 24, 2023
Serial Number
79171327
Registration Number
5084124
Registration Date
Tuesday, November 22, 2016
Mark Type
3000
Filing Date
Tuesday, May 12, 2015
Published for Opposition
Tuesday, February 16, 2016

Trademark Owner History
Baxalta Incorporated - Original Registrant

Classifications
41 [ Education and training services, namely, providing classes, seminars, conferences, lectures and workshops in the fields of pharmaceuticals, health care, health insurance, medical information, bleeding disorders or conditions, hemophilia, hematology, immunology, oncology and patient care; education services, namely, providing printed publications in the nature of newsletters and white papers in the field of hemophilia; provision of information for training and teaching relating to pharmaceuticals, health care, health insurance, medical information, bleeding disorders or conditions, hemophilia, hematology, immunology, oncology and patient care; provision of non-downloadable electronic publications, namely, newsletters, articles, brochures and booklets in the field of pharmaceuticals, health care, health insurance, medical information, bleeding disorders or conditions, hemophilia, hematology, immunology, oncology and patient care ]
5 Pharmaceutical preparations, substances and products for the treatment of blood diseases and disorders, immuno deficiency disorders, cancer; pharmaceuticals for the treatment of blood diseases and disorders, immuno deficiency disorders, cancer; pharmaceutical preparations, namely, proteinase inhibitors in the nature of alpha-1 proteinase inhibitors; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, all containing immune globulin infusion (human) and recombinant human hyaluronidase; reconstitution assembly sold containing vials prefilled with pharmaceutical preparations for the treatment of blood diseases and disorders; normal serum albumin (human) solution for intravenous administration; immunoglobulin for parenteral, intramuscular and intravenous administration to humans; antihemophilic factor for intravenous administration in humans; antihemophilic factor recombinant; pharmaceutical preparations, namely, chemotherapeutic agents
10 Medical devices, namely, devices for reconstituting dried pharmaceuticals; medical apparatus and instruments, namely, medical infusion set for subcutaneous delivery of pharmaceuticals; medical apparatus for the preparation and parental infusion of pharmaceutical preparations
The mark consists of the word "BAXALTA" with light rays emanating from the center of the letter "X".
Color is not claimed as a feature of the mark.

Trademark Events
Nov 20, 2023
Partial Invalidation Processed By The Ib
Oct 26, 2023
Partial Invalidation Of Reg Ext Protection Sent To Ib
Oct 26, 2023
Invalidation Processed
Oct 24, 2023
Partial Invalidation Of Reg Ext Protection Created
Feb 24, 2023
Notice Of Acceptance Of Sec. 71 - E-Mailed
Feb 24, 2023
Registered - Partial Sec 71 Accepted
Feb 24, 2023
Case Assigned To Post Registration Paralegal
Oct 22, 2022
New Representative At Ib Received
Oct 21, 2022
New Representative At Ib Received
Aug 22, 2022
Teas Section 71 Received
Nov 22, 2021
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Mar 25, 2017
Final Decision Transaction Processed By Ib
Mar 7, 2017
Final Disposition Notice Sent To Ib
Mar 7, 2017
Final Disposition Processed
Feb 22, 2017
Final Disposition Notice Created, To Be Sent To Ib
Nov 22, 2016
Registered-Principal Register
Sep 15, 2016
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 15, 2016
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 1, 2016
Extension Of Time To Oppose Process - Terminated
Mar 16, 2016
Extension Of Time To Oppose Received
Feb 16, 2016
Changes/Corrections After Pub Approval Entered
Feb 16, 2016
Official Gazette Publication Confirmation E-Mailed
Feb 16, 2016
Published For Opposition
Feb 13, 2016
Notification Processed By Ib
Feb 5, 2016
Assigned To Petition Staff
Jan 27, 2016
Notification Of Possible Opposition Sent To Ib
Jan 27, 2016
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jan 27, 2016
Notification Of Notice Of Publication E-Mailed
Jan 18, 2016
Teas Post Publication Amendment Received
Jan 12, 2016
Law Office Publication Review Completed
Jan 5, 2016
Approved For Pub - Principal Register
Dec 18, 2015
Teas/Email Correspondence Entered
Dec 18, 2015
Correspondence Received In Law Office
Dec 18, 2015
Applicant/Correspondence Changes (Non-Responsive) Entered
Dec 18, 2015
Assigned To Lie
Dec 4, 2015
Teas Response To Office Action Received
Nov 19, 2015
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 19, 2015
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 25, 2015
Refusal Processed By Ib
Sep 8, 2015
Non-Final Action Mailed - Refusal Sent To Ib
Sep 8, 2015
Refusal Processed By Mpu
Sep 8, 2015
Application Filing Receipt Mailed
Sep 6, 2015
Non-Final Action (Ib Refusal) Prepared For Review
Sep 5, 2015
Non-Final Action Written
Sep 2, 2015
Assigned To Examiner
Sep 2, 2015
New Application Office Supplied Data Entered
Aug 27, 2015
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24